Dihydrocapsaicin-d3 is a deuterated form of dihydrocapsaicin, which acts as a potent and selective TRPV1 (Transient Receptor Potential Vanilloid 1) agonist; it reduces the expression of AIF, Bax, and Caspase-3, while increasing the levels of Bcl-2, Bcl-xL, and p-Akt; it enhances hypothermia-induced neuroprotection following ischemic stroke in rats through PI3K/Akt modulation.